HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Beecham

This article was originally published in The Rose Sheet

Executive Summary

Jean-Pierre Garnier succeeds Jan Leschly as CEO April 28; Garnier also is set to become CEO of Glaxo SmithKline following the merger of SB and Glaxo-Wellcome. Garnier, 52, joined SmithKline in 1990 as president of the company's North America pharmaceutical business and took over worldwide operations in 1994. He became chief operating officer in 1995. Leschly retires after serving as SmithKline CEO since 1994. During the pair's collaboration, SB's consumer healthcare division became the second largest worldwide
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS007983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel